Mimedx (MDXG) Inventory (2010 - 2026)
Mimedx (MDXG) posted Inventory of $20.9 million for Q2 2026, down 20.2% sequentially from $26.2 million in Q1 2026, and down 15.91% YoY from $24.9 million in Q2 2025.
Mimedx (MDXG) Inventory (2010 - 2026) Analysis & Trends
Mimedx has reported Inventory for 17 years, with the latest figure at $20.9 million in Q2 2026.
- Quarterly Inventory fell 15.91% year-over-year to $20.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $20.9 million (down 15.91% YoY) and the FY2025 annual result came in at $25.3 million, up 6.44% from the prior year.
- Inventory eased to $20.9 million in Q2 2026 per MDXG's latest filing, from $26.2 million in the prior quarter.
- Over five years, Inventory peaked at $26.5 million in Q3 2025 and troughed at $13.2 million in Q1 2022.
- A 5-year average of $20.6 million and a median of $22.4 million in 2023 frame the typical range for Inventory.
- The sharpest annual moves came in 2024 and 2026: Inventory surged 66.84% in 2024, then fell 15.91% in 2026.
- Over 5 years, Inventory stood at $13.2 million in 2022, then soared by 59.46% to $21.0 million in 2023, then grew by 13.25% to $23.8 million in 2024, then increased by 6.44% to $25.3 million in 2025, then decreased by 17.4% to $20.9 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $20.9 million, $26.2 million, and $25.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Mimedx | 622.24 Mn | 486.40 Mn | 44.38 Mn | 20.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.93 Mn |
| Mar 31, 2026 | 26.23 Mn |
| Dec 31, 2025 | 25.34 Mn |
| Sep 30, 2025 | 26.50 Mn |
| Jun 30, 2025 | 24.89 Mn |
| Mar 31, 2025 | 24.07 Mn |
| Dec 31, 2024 | 23.81 Mn |
| Sep 30, 2024 | 24.25 Mn |
| Jun 30, 2024 | 25.06 Mn |
| Mar 31, 2024 | 24.45 Mn |
| Dec 31, 2023 | 21.02 Mn |
| Sep 30, 2023 | 19.07 Mn |
| Jun 30, 2023 | 16.82 Mn |
| Mar 31, 2023 | 14.66 Mn |
| Dec 31, 2022 | 13.18 Mn |
| Sep 30, 2022 | 13.98 Mn |
| Jun 30, 2022 | 13.38 Mn |
| Mar 31, 2022 | 13.17 Mn |
| Dec 31, 2021 | 11.39 Mn |
| Sep 30, 2021 | 11.20 Mn |